↓ Skip to main content

Cochrane Database of Systematic Reviews

Transdermal fentanyl for cancer pain

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
1 policy source
twitter
45 tweeters

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
201 Mendeley
Title
Transdermal fentanyl for cancer pain
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd010270.pub2
Pubmed ID
Authors

Gina Hadley, Sheena Derry, R Andrew Moore, Philip J Wiffen

Abstract

Opioid drugs have been used for many years to relieve pain. Transdermal fentanyl offers one option for delivering and maintaining pain relief in patients with moderate or severe cancer pain.

Twitter Demographics

The data shown below were collected from the profiles of 45 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Spain 1 <1%
France 1 <1%
Unknown 198 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 34 17%
Student > Bachelor 26 13%
Researcher 25 12%
Student > Ph. D. Student 23 11%
Student > Postgraduate 15 7%
Other 42 21%
Unknown 36 18%
Readers by discipline Count As %
Medicine and Dentistry 89 44%
Nursing and Health Professions 19 9%
Psychology 12 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Agricultural and Biological Sciences 5 2%
Other 25 12%
Unknown 45 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2021.
All research outputs
#889,164
of 18,920,065 outputs
Outputs from Cochrane database of systematic reviews
#2,184
of 11,892 outputs
Outputs of similar age
#9,432
of 182,353 outputs
Outputs of similar age from Cochrane database of systematic reviews
#19
of 106 outputs
Altmetric has tracked 18,920,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,892 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,353 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.